Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy C4 Therapeutics Inc stock

Learn how to easily invest in C4 Therapeutics Inc stock.

C4 Therapeutics Inc is a biotechnology business based in the US. C4 Therapeutics Inc shares (CCCC) are listed on the NASDAQ and all prices are listed in US Dollars. C4 Therapeutics Inc employs 121 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in C4 Therapeutics Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CCCC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

C4 Therapeutics Inc stock price (NASDAQ: CCCC)

Use our graph to track the performance of CCCC stocks over time.

C4 Therapeutics Inc shares at a glance

Information last updated 2022-06-30.
Latest market close$8.03
52-week range$4.84 - $51.21
50-day moving average $7.25
200-day moving average $25.85
Wall St. target price$29.64
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.99

Buy C4 Therapeutics Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy C4 Therapeutics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

C4 Therapeutics Inc price performance over time

Historical closes compared with the close of $8.03 from 2022-07-01

1 week (2022-06-28) 12.31%
1 month (2022-06-01) N/A
3 months (2022-04-05) -63.50%
6 months (2022-01-05) -72.90%
1 year (2021-07-02) -79.78%
2 years (2020-07-01) N/A
3 years (2019-07-01) N/A
5 years (2017-07-01) N/A

C4 Therapeutics Inc financials

Revenue TTM $46 million
Gross profit TTM $-41,354,000
Return on assets TTM -13.07%
Return on equity TTM -30.1%
Profit margin -205.47%
Book value $7.48
Market capitalisation $367.9 million

TTM: trailing 12 months

C4 Therapeutics Inc share dividends

We're not expecting C4 Therapeutics Inc to pay a dividend over the next 12 months.

C4 Therapeutics Inc overview

C4 Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable BiDAC degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies; CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC; and earlier stage programs comprising RET degraders for the treatment of various cancers. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.

Frequently asked questions

What percentage of C4 Therapeutics Inc is owned by insiders or institutions?
Currently 11.28% of C4 Therapeutics Inc shares are held by insiders and 92.989% by institutions.
How many people work for C4 Therapeutics Inc?
Latest data suggests 121 work at C4 Therapeutics Inc.
When does the fiscal year end for C4 Therapeutics Inc?
C4 Therapeutics Inc's fiscal year ends in December.
Where is C4 Therapeutics Inc based?
C4 Therapeutics Inc's address is: 490 Arsenal Way, Watertown, MA, United States, 02472
What is C4 Therapeutics Inc's ISIN number?
C4 Therapeutics Inc's international securities identification number is: US12529R1077

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site